Insulin Humulin® NPH + Insulin Rinsulin® NPH
Phase 3Completed 1 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Type 2
Conditions
Diabetes Mellitus, Type 2
Trial Timeline
Apr 20, 2017 → Sep 24, 2018
NCT ID
NCT04012775About Insulin Humulin® NPH + Insulin Rinsulin® NPH
Insulin Humulin® NPH + Insulin Rinsulin® NPH is a phase 3 stage product being developed by GEROPHARM for Diabetes Mellitus, Type 2. The current trial status is completed. This product is registered under clinical trial identifier NCT04012775. Target conditions include Diabetes Mellitus, Type 2.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus, Type 2 were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04012775 | Phase 3 | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Type 2